Biren Amin Analyst PerformanceAnalyst at Jefferies Financial GroupBiren Amin is a stock analyst at Jefferies Financial Group in the healthcare sector, covering 39 publicly traded companies. Over the past year, Biren Amin has issued 32 stock ratings, including buy and hold recommendations. While full access to Biren Amin's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Biren Amin's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings111 Last 12 YearsBuy Recommendations81.65% 89 Buy RatingsCompanies Covered39 Unique Companies Ratings Distribution109RatingsDistribution of strong buy, buy, hold, and sell ratings by Biren Amin.RatingPercentageCount Strong Buy0.0%0 ratings Buy81.7%89 ratings Hold17.4%19 ratings Sell0.9%1 ratingsOut of 109 total stock ratings issued by Biren Amin at Jefferies Financial Group, the majority (81.7%) have been Buy recommendations, followed by 17.4% Hold and 0.9% Sell.Best & Worst CallsBest Call0000.0%ACRSJul 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ADVMJun 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ97.4% of companies on NASDAQ38 companiesNYSEAMERICAN2.6% of companies on NYSEAMERICAN1 companyBiren Amin, an analyst at Jefferies Financial Group, currently covers 39 companies listed on NASDAQ and NYSEAMERICAN, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare39 companies100.0%Biren Amin of Jefferies Financial Group specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY31 companies79.5%PHARMACEUTICALS8 companies20.5% Biren Amin's Ratings History at Jefferies Financial Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsIMTXImmatics8/25/2026Set Price Target$9.24$17.00$0.0000.00% ROINERVMinerva Neurosciences8/14/2026Upgrade$3.92$10.00Mixed$0.0000.00% ROILENZLENZ Therapeutics8/12/2026Lower Price Target$5.21$7.00Neutral$0.0000.00% ROIJSPRJasper Therapeutics8/12/2026Initiated Coverage$0.89$2.00Overweight$0.0000.00% ROIJSPRJasper Therapeutics8/12/2026Initiated Coverage$0.82$2.00Overweight$0.0000.00% ROICATXPerspective Therapeutics8/11/2026Lower Price Target$3.00$14.00Overweight$0.0000.00% ROIBBIOBridgeBio Pharma8/11/2026Boost Price Target$84.67$115.00Overweight$0.0000.00% ROICMPXCompass Therapeutics8/7/2026Boost Price Target$2.15$6.00Overweight$0.0000.00% ROISRPTSarepta Therapeutics7/9/2026Lower Price Target$20.32$20.00Neutral$0.0000.00% ROIREGNRegeneron Pharmaceuticals7/9/2026Lower Price Target$664.12$854.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CNTBConnect Biopharma6/26/2026Initiated Coverage$2.07$7.00Overweight$0.0000.00% ROICNTBConnect Biopharma6/26/2026Initiated Coverage$2.21$7.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals5/18/2026Lower Price Target$623.32$855.00Overweight$0.0000.00% ROISLDBSolid Biosciences5/13/2026Reiterated Rating$7.72$18.00Overweight$0.0000.00% ROILENZLENZ Therapeutics5/12/2026Downgrade$9.99$12.00Neutral$0.0000.00% ROIACRSAclaris Therapeutics5/5/2026Boost Price Target$4.53$11.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals3/31/2026Initiated Coverage$749.29$875.00Overweight$0.0000.00% ROICNTXContext Therapeutics3/24/2026Boost Price Target$3.02$7.00Overweight$0.0000.00% ROIIMTXImmatics3/16/2026Initiated Coverage$9.71$18.00Buy$0.0000.00% ROIALLOAllogene Therapeutics3/13/2026Boost Price Target$2.39$8.00Overweight$0.0000.00% ROIKYMRKymera Therapeutics2/26/2026Boost Price Target$89.09$140.00Overweight$0.0000.00% ROIOKYOOKYO Pharma2/20/2026Initiated Coverage$1.76$7.00Overweight$0.0000.00% ROIOKYOOKYO Pharma2/20/2026Initiated Coverage$1.70$7.00Overweight$0.0000.00% ROICATXPerspective Therapeutics2/19/2026Initiated Coverage$5.03$16.00Overweight$0.0000.00% ROICATXPerspective Therapeutics2/19/2026Initiated Coverage$5.65$16.00Overweight$0.0000.00% ROIIRDOpus Genetics11/25/2025Initiated Coverage$2.00$7.00Overweight$0.0000.00% ROIAAPGAscentage Pharma Group International11/5/2025Initiated Coverage$33.25$48.00Overweight$0.0000.00% ROISRPTSarepta Therapeutics10/30/2025Boost Price Target$23.20$16.00Neutral$0.0000.00% ROIBBIOBridgeBio Pharma10/30/2025Boost Price Target$65.44$98.00Overweight$0.0000.00% ROILENZLENZ Therapeutics10/10/2025Boost Price Target$46.25$67.00Overweight$0.0000.00% ROIOCULOcular Therapeutix10/3/2025Boost Price Target$11.06$31.00Overweight$0.0000.00% ROIMNPRMonopar Therapeutics9/25/2025Set Price Target$72.87$95.00Overweight$0.0000.00% ROISRPTSarepta Therapeutics7/29/2025Boost Price Target$13.86$15.00Neutral$00.0000.00% ROIKLRSKalaris Therapeutics7/23/2025Set Price Target$2.57$3.00Neutral$0.0000.00% ROISRPTSarepta Therapeutics7/21/2025Lower Price Target$13.79$18.00Neutral$00.0000.00% ROIBBIOBridgeBio Pharma7/14/2025Boost Price Target$46.47$68.00Overweight$00.0000.00% ROIACRSAclaris Therapeutics7/10/2025Initiated Coverage$1.62$6.00Overweight$0.0000.00% ROICNTXContext Therapeutics6/26/2025Reiterated Rating$0.64$4.00Overweight$0.0000.00% ROISRPTSarepta Therapeutics6/16/2025Downgrade$36.18$36.00Neutral$00.0000.00% ROISLDBSolid Biosciences5/16/2025Lower Price Target$2.84$17.00Overweight$0.0000.00% ROIYour book attached (Ad)Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.Download the Safe Trade Options Formula book for free before access closesALLOAllogene Therapeutics5/14/2025Lower Price Target$0.93$7.00Overweight$0.0000.00% ROISRPTSarepta Therapeutics5/7/2025Lower Price Target$38.37$70.00Overweight$00.0000.00% ROIBBIOBridgeBio Pharma4/30/2025Boost Price Target$38.50$63.00Overweight$00.0000.00% ROISRPTSarepta Therapeutics4/21/2025Lower Price Target$53.62$110.00Overweight$00.0000.00% ROILENZLENZ Therapeutics4/14/2025Initiated Coverage$21.95$51.00Overweight$0.0000.00% ROICNTACentessa Pharmaceuticals3/31/2025Initiated Coverage$14.59$38.00Overweight$00.0000.00% ROICMPXCompass Therapeutics2/19/2025Initiated Coverage$3.17$12.00Overweight$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageCitigroupUBS GroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsMizuho Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
